Latest United States Startup Funding Rounds
Startup funding in United States: recent rounds, the companies behind them and their participating investors.
- Rounds
- 2,220 Jan 1 – Oct 25, 2026
- Disclosed funding
- $248.4B 1843 disclosed amounts
- Median round
- $24M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| CM Cambridge Mobile TelematicsCompany profile Provides AI-driven road safety platform with telematics and data solutions Provides AI-driven road safety platform with telematics and data solutions | $350M | StrategicUndisclosed | Fintech | United States | Investors | |
| S ShepherdCompany profile Provides AI-native commercial insurance platform for construction and infrastructure projects Provides AI-native commercial insurance platform for construction and infrastructure projects | $42M | Series B | Fintech | United States | Investors | |
| SS Produces better-for-you pretzels with clean ingredients | Undisclosed | StrategicUndisclosed | Foodtech | United States | Investors | |
| PP Pro Padel LeagueCompany profile Professional padel league with 10 franchise teams across the US, Canada, and Mexico Professional padel league with 10 franchise teams across the US, Canada, and Mexico | $15M | Series A | Consumer | United States | Investors | |
| VM Virchow MedicalCompany profile Provides biopsy specimen stewardship and expands access to precision oncology Provides biopsy specimen stewardship and expands access to precision oncology | $4M | Seed | Healthtech | United States | Investors | |
| D DossCompany profile Provides AI-native inventory management layer that integrates with existing accounting systems Provides AI-native inventory management layer that integrates with existing accounting systems | $55M | Series B | Enterprise software | United States | Investors | |
| GP Gilgamesh PharmaCompany profile Develops novel chemical entities for psychiatric and neurological disorders Develops novel chemical entities for psychiatric and neurological disorders | $60M | Series A | Biotech | United States | Investors | |
| B Builds AI product planning tools for non-technical founders | $1M | Pre-SeedPre-seed | AI | United States | Investors | |
| R RyboDynCompany profile Decodes the dark proteome using an AI-powered novel sequencing and discovery platform to reveal novel cancer targets Decodes the dark proteome using an AI-powered novel sequencing and discovery platform to reveal novel cancer targets | $10M | Seed | Biotech | United States | Investors | |
| T Provides a unified API layer for cross-border payments and financial inclusion | $7.5M | Series A | Fintech | United States | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · From Jan 1, 2026
- 1Y Combinator (YC)
BioStack, Tractian, Blacksmith
132rounds3led - 2Andreessen Horowitz (a16z)
ASI, Eka Robotics, Town
98rounds19led - 3General Catalyst
Tractian, Different, Baba
69rounds7led - 4Alumni Ventures
Maxinsights, Daytona, Chariot Claims
60rounds0led - 5Khosla Ventures
Arda Industries, Tolan
58rounds6led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.